Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,695 | 43,075 | 4,205 | 12,079 | 1,463 |
| Marketable Securities | 20,192 | 51,831 | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 22,338 |
| Inventories | N/A | N/A | N/A | N/A | 27,220 |
| TOTAL | $73,962 | $102,101 | $5,126 | $12,494 | $51,711 |
| Non-Current Assets | |||||
| PPE Net | 777 | N/A | N/A | N/A | 36,984 |
| Investments And Advances | 0 | 30,973 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,099 | 0 | 0 | 0 | 10,603 |
| TOTAL | $4,876 | $30,973 | $N/A | $N/A | $47,587 |
| Total Assets | $78,838 | $133,074 | $5,126 | $12,494 | $99,298 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 57,716 |
| Accounts payable and accrued liabilities | 3,385 | 2,297 | 2,234 | 1,628 | 17,193 |
| Accrued Expenses | 5,994 | 5,578 | 3,100 | 1,694 | N/A |
| Other current liabilities | N/A | N/A | 300 | N/A | 7,563 |
| TOTAL | $9,379 | $7,875 | $5,634 | $3,322 | $82,472 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 96,928 | 71,973 | 20,168 |
| TOTAL | $N/A | $N/A | $96,928 | $71,973 | $20,717 |
| Total Liabilities | $9,379 | $7,875 | $102,562 | $75,295 | $103,189 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,631 | 21,618 | N/A | N/A | 6,403 |
| Common Shares | 2 | 2 | 1 | 1 | 75 |
| Retained earnings | -201,476 | -140,071 | -97,437 | -62,802 | -15,194 |
| Other shareholders' equity | -14 | -74 | 0 | 0 | -8,101 |
| TOTAL | $69,459 | $125,199 | $-97,436 | $-62,801 | $-3,891 |
| Total Liabilities And Equity | $78,838 | $133,074 | $5,126 | $12,494 | $99,298 |